Cargando…
Vitamin D and methylarginines in chronic kidney disease (CKD)
BACKGROUND: Vitamin D associates with the plasma concentration of the endogenous inhibitor of the nitric oxide system asymmetric dimethyl arginine (ADMA) and cross-sectional studies in CKD patients treated with the vitamin D receptor activator paricalcitol show that plasma ADMA is substantially less...
Autores principales: | Torino, Claudia, Pizzini, Patrizia, Cutrupi, Sebastiano, Tripepi, Rocco, Tripepi, Giovanni, Mallamaci, Francesca, Zoccali, Carmine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627906/ https://www.ncbi.nlm.nih.gov/pubmed/28976989 http://dx.doi.org/10.1371/journal.pone.0185449 |
Ejemplares similares
-
Effect of Vitamin D Receptor Activation on the AGE/RAGE System and Myeloperoxidase in Chronic Kidney Disease Patients
por: Torino, Claudia, et al.
Publicado: (2017) -
Serum Erythroferrone Levels Associate with Mortality and Cardiovascular Events in Hemodialysis and in CKD Patients: A Two Cohorts Study
por: Spoto, Belinda, et al.
Publicado: (2019) -
Soluble Urokinase Plasminogen Activator Receptor (suPAR) and All-Cause and Cardiovascular Mortality in Diverse Hemodialysis Patients
por: Torino, Claudia, et al.
Publicado: (2018) -
Pro-inflammatory cytokines and bone fractures in CKD patients. An exploratory single centre study
por: Panuccio, Vincenzo, et al.
Publicado: (2012) -
Homoarginine and Mortality in Pre-Dialysis Chronic Kidney Disease (CKD) Patients
por: Ravani, Pietro, et al.
Publicado: (2013)